MedPath
FDA Approval

Cleviprex

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Chiesi USA, Inc.
DUNS: 088084228
Effective Date
September 6, 2022
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Clevidipine(0.5 mg in 1 mL)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Chiesi USA, Inc.

088084228

Products2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Cleviprex

Product Details

NDC Product Code
10122-610
Application Number
NDA022156
Marketing Category
NDA (C73594)
Route of Administration
INTRAVENOUS
Effective Date
September 6, 2022
Code: 19O2GP3B7QClass: ACTIBQuantity: 0.5 mg in 1 mL
OLEIC ACIDInactive
Code: 2UMI9U37CPClass: IACT
GLYCERINInactive
Code: PDC6A3C0OXClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
EDETATE DISODIUMInactive
Code: 7FLD91C86KClass: IACT
SOYBEAN OILInactive
Code: 241ATL177AClass: IACT
EGG PHOSPHOLIPIDSInactive
Code: 1Z74184RGVClass: IACT

Cleviprex

Product Details

NDC Product Code
10122-611
Application Number
NDA022156
Marketing Category
NDA (C73594)
Route of Administration
INTRAVENOUS
Effective Date
September 6, 2022
EDETATE DISODIUMInactive
Code: 7FLD91C86KClass: IACT
Code: 19O2GP3B7QClass: ACTIBQuantity: 0.5 mg in 1 mL
OLEIC ACIDInactive
Code: 2UMI9U37CPClass: IACT
EGG PHOSPHOLIPIDSInactive
Code: 1Z74184RGVClass: IACT
SOYBEAN OILInactive
Code: 241ATL177AClass: IACT
GLYCERINInactive
Code: PDC6A3C0OXClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
© Copyright 2025. All Rights Reserved by MedPath